Pharmafile Logo
Pharmafocus logo
Advanced Search

Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data

March 22, 2023
Business Services

Boston, March 22, 2023 — YonaLink, a clinical trial software provider, today announced its EHR-to-EDC data integration platform has been …

News
Press release

Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers

March 22, 2023
Business Services

HERCULES, Calif. — March 15, 2023 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science …

News
Press release

InvoX Pharma’s F-star announces licence agreement with Takeda for second novel next-generation immuno-oncology bispecific antibody

March 22, 2023
Business Services

LONDON, United Kingdom, March, 22, 2023 (GLOBE NEWSWIRE): InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited …

News
Press release

Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression

March 22, 2023
Business Services

Boston, Massachusetts March 22, 2023 – Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify …

News
Press release

ELLAB LAUNCHES NEW MONITORING SOLUTION FOR LIFE-SAVING PRODUCTS

March 22, 2023
Business Services

Ellab has launched a new continuous monitoring solution for the biotech and pharmaceutical sectors, which accurately monitors critical processes 24/7. …

News
Press release

CANARY WHARF ATTRACTS LIFE SCIENCES FOCUSED STARTUPS AND SCALEUPS TO ITS TECHNOLOGY COMMUNITY AT LEVEL39

March 22, 2023
Business Services

22 March 2023: The development of a major life science cluster at Canary Wharf continues to build momentum with a …

News
Press release

Sequana Medical announces additional patents for DSR® in China and the United States

March 22, 2023
Business Services

Ghent, Belgium – 22 March 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Roche and Eli Lilly collaborate on Alzheimer’s disease blood test

March 22, 2023
Medical Communications

Swiss biotech company Roche has announced a collaboration with US pharmaceutical company Eli Lilly to develop Roche’s Elecsys Amyloid Plasma …

News

Kite’s Yescarta CAR T-cell therapy shows statistically significant improvement in overall survival

March 22, 2023
Research and Development

Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment …

News

Promising ovarian cancer drug enters phase 3 trial

March 22, 2023

A new drug to treat ovarian cancer is set to enter the phase 3 UP-NEXT trial imminently.  Upifitamab rilsodotin is …

News

Faron Pharmaceuticals announces positive FDA feedback for solid tumour therapy

March 22, 2023
Research and Development

Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for solid tumour …

News

Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions

March 21, 2023
Business Services

OXFORD, United Kingdom, March 20, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …

News
Press release

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023
Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …

News

First candidate from Nurix-Gilead Sciences collaboration exclusively licensed

March 21, 2023
Research and Development

US-based Gilead Sciences and Nurix have announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted protein …

News

FDA staff appear to support Biogen’s ALS drug despite limited data

March 21, 2023
Medical Communications

It appears that the FDA is inclined to support Biogen’s amyotrophic lateral sclerosis (ALS) drug, tofersen, with documents released on …

News

FDA approves Surgvision’s Explorer Air II device

March 21, 2023
Medical Communications

Medical technology company Surgvision has announced that it has received FDA 510(k) approval for its Explorer Air II device. It …

News

Mobiquity Report Reveals Top Mobile Health App Features that help to increase patient engagement.

March 20, 2023
Business Services

Mobiquity, a digital consultancy that designs and delivers innovative digital products and services for the world’s leading brands, released today …

News
Press release

AbbVie shares results from study for new psoriasis therapy

March 20, 2023
Research and Development

AbbVie has announced new 52-week data from a study assessing the efficacy of new IL-23 inhibitor, Skyrizi (risankizumab). Patients with …

News

QurAlis Corporation announces programme which targets UNC13A mis-splicing in neurodegenerative diseases

March 20, 2023
Research and Development

US-based clinical-stage biotechnology QurAlis Corporation has announced the launch of its newest programme to treat neurodegenerative diseases like ALS and …

News

AstraZeneca and MSD announce MHRA marketing authorisation of Lynparza combination therapy

March 20, 2023
Medical Communications

AstraZeneca and MSD have announced that the MHRA has granted marketing authorisation for Lynparza (olaparib) in the UK, when used …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026